Quick Summary:
In an ever-evolving global healthcare landscape, the Artificial Insemination Market continues its robust growth trajectory, illustrating a promising investment horizon for stakeholders. This comprehensive report offers data-driven nuances that exhibit how the market is projected to expand from a commendable US$2.3 billion in 2022 to an impressive US$4.1 billion by 2030.
The analysis details key segmentations, such as Intrauterine, expected to record a 7.7% CAGR and reach US$2.5 billion within the review period. It also provides country-specific data, highlighting lucrative markets—the U.S., China, Japan, Germany and more. Furthermore, diving deep into healthy competition, the report provides a strategic overview of 41 competitors including notable names like Genea Limited and Irvine Scientific. Stay ahead in this high-growth market with our report, packed with valuable insights and strategic perspectives.
Global Artificial Insemination Market to Reach $4.1 Billion by 2030
The global market for Artificial Insemination estimated at US$2.3 Billion in the year 2022, is projected to reach a revised size of US$4.1 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2022-2030. Intrauterine, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$2.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Intracervical segment is readjusted to a revised 7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $709 Million, While China is Forecast to Grow at 6.7% CAGR
The Artificial Insemination market in the U.S. is estimated at US$709 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$703.4 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 5.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.Select Competitors (Total 41 Featured) -
- Genea Limited
- Hi-Tech Solutions
- Irvine Scientific
- KITAZATO CORPORATION
- Pride Angel Ltd.
- Rinovum Women's Health, LLC.
- Rocket Medical PLC
- Vitrolife AB
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Artificial Insemination?
What is the growth rate of the Global Market for Artificial Insemination?
What is the forecasted size of the Global Market for Artificial Insemination?
Who are the key companies in the Global Market for Artificial Insemination?
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | November 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 2.3 Billion |
| Forecasted Market Value ( USD | $ 4.1 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Genea Limited
- Hi-Tech Solutions
- Irvine Scientific
- KITAZATO CORPORATION
- Pride Angel Ltd.
- Rinovum Women's Health, LLC.
- Rocket Medical PLC
- Vitrolife AB
